251 related articles for article (PubMed ID: 28254618)
1. Parkin promotes proteasomal degradation of synaptotagmin IV by accelerating polyubiquitination.
Kabayama H; Tokushige N; Takeuchi M; Kabayama M; Fukuda M; Mikoshiba K
Mol Cell Neurosci; 2017 Apr; 80():89-99. PubMed ID: 28254618
[TBL] [Abstract][Full Text] [Related]
2. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI.
Huynh DP; Scoles DR; Nguyen D; Pulst SM
Hum Mol Genet; 2003 Oct; 12(20):2587-97. PubMed ID: 12925569
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor-dependent sorting of synaptotagmin IV protein to mature dense-core vesicles that undergo calcium-dependent exocytosis in PC12 cells.
Fukuda M; Kanno E; Ogata Y; Saegusa C; Kim T; Loh YP; Yamamoto A
J Biol Chem; 2003 Jan; 278(5):3220-6. PubMed ID: 12446703
[TBL] [Abstract][Full Text] [Related]
4. STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson's disease.
Kurup PK; Xu J; Videira RA; Ononenyi C; Baltazar G; Lombroso PJ; Nairn AC
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1202-7. PubMed ID: 25583483
[TBL] [Abstract][Full Text] [Related]
5. Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels.
Joch M; Ase AR; Chen CX; MacDonald PA; Kontogiannea M; Corera AT; Brice A; Séguéla P; Fon EA
Mol Biol Cell; 2007 Aug; 18(8):3105-18. PubMed ID: 17553932
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats.
Glavan G; Zivin M
Neuroscience; 2005; 135(2):545-54. PubMed ID: 16111820
[TBL] [Abstract][Full Text] [Related]
7. Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson's disease-like pathology.
Wang C; Kang X; Zhou L; Chai Z; Wu Q; Huang R; Xu H; Hu M; Sun X; Sun S; Li J; Jiao R; Zuo P; Zheng L; Yue Z; Zhou Z
Nat Commun; 2018 Jan; 9(1):81. PubMed ID: 29311685
[TBL] [Abstract][Full Text] [Related]
8. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease.
Song P; Li S; Wu H; Gao R; Rao G; Wang D; Chen Z; Ma B; Wang H; Sui N; Deng H; Zhang Z; Tang T; Tan Z; Han Z; Lu T; Zhu Y; Chen Q
Protein Cell; 2016 Feb; 7(2):114-29. PubMed ID: 26746706
[TBL] [Abstract][Full Text] [Related]
9. Synaptotagmin-IV modulates synaptic function and long-term potentiation by regulating BDNF release.
Dean C; Liu H; Dunning FM; Chang PY; Jackson MB; Chapman ER
Nat Neurosci; 2009 Jun; 12(6):767-76. PubMed ID: 19448629
[TBL] [Abstract][Full Text] [Related]
10. Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson's disease.
Romaní-Aumedes J; Canal M; Martín-Flores N; Sun X; Pérez-Fernández V; Wewering S; Fernández-Santiago R; Ezquerra M; Pont-Sunyer C; Lafuente A; Alberch J; Luebbert H; Tolosa E; Levy OA; Greene LA; Malagelada C
Cell Death Dis; 2014 Aug; 5(8):e1364. PubMed ID: 25101677
[TBL] [Abstract][Full Text] [Related]
11. Parkin-dependent and -independent degradation of synaptotagmin-11 in neurons and astrocytes.
Wang Y; Yan S; Zhang F; Li J; Li R; Zhang CX
Neurosci Lett; 2020 Nov; 739():135402. PubMed ID: 32976921
[TBL] [Abstract][Full Text] [Related]
12. Upregulation and axonal transport of synaptotagmin-IV in the direct-pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation.
Tratnjek L; Glavan G; Višnjar T; Živin M
Eur J Neurosci; 2016 Apr; 43(7):885-98. PubMed ID: 26750488
[TBL] [Abstract][Full Text] [Related]
13. Impaired dopamine release and synaptic plasticity in the striatum of parkin-/- mice.
Kitada T; Pisani A; Karouani M; Haburcak M; Martella G; Tscherter A; Platania P; Wu B; Pothos EN; Shen J
J Neurochem; 2009 Jul; 110(2):613-21. PubMed ID: 19457102
[TBL] [Abstract][Full Text] [Related]
14. Effect of forskolin on synaptotagmin IV protein trafficking in PC12 cells.
Fukuda M; Yamamoto A
J Biochem; 2004 Aug; 136(2):245-53. PubMed ID: 15496596
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma membrane localization of O-glycosylation-deficient mutant of synaptotagmin I in PC12 cells.
Kanno E; Fukuda M
J Neurosci Res; 2008 Apr; 86(5):1036-43. PubMed ID: 18058942
[TBL] [Abstract][Full Text] [Related]
16. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling.
Fallon L; Bélanger CM; Corera AT; Kontogiannea M; Regan-Klapisz E; Moreau F; Voortman J; Haber M; Rouleau G; Thorarinsdottir T; Brice A; van Bergen En Henegouwen PM; Fon EA
Nat Cell Biol; 2006 Aug; 8(8):834-42. PubMed ID: 16862145
[TBL] [Abstract][Full Text] [Related]
17. Synaptotagmin IV: a multifunctional regulator of peptidergic nerve terminals.
Zhang Z; Bhalla A; Dean C; Chapman ER; Jackson MB
Nat Neurosci; 2009 Feb; 12(2):163-71. PubMed ID: 19136969
[TBL] [Abstract][Full Text] [Related]
18. Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis.
Casarejos MJ; Solano RM; Rodriguez-Navarro JA; Gómez A; Perucho J; Castaño JG; García de Yébenes J; Mena MA
J Neurochem; 2009 Sep; 110(5):1523-37. PubMed ID: 19549073
[TBL] [Abstract][Full Text] [Related]
19. Parkin Knockout Inhibits Neuronal Development via Regulation of Proteasomal Degradation of p21.
Park MH; Lee HJ; Lee HL; Son DJ; Ju JH; Hyun BK; Jung SH; Song JK; Lee DH; Hwang CJ; Han SB; Kim S; Hong JT
Theranostics; 2017; 7(7):2033-2045. PubMed ID: 28656059
[TBL] [Abstract][Full Text] [Related]
20. Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons.
Son JH; Kawamata H; Yoo MS; Kim DJ; Lee YK; Kim S; Dawson TM; Zhang H; Sulzer D; Yang L; Beal MF; Degiorgio LA; Chun HS; Baker H; Peng C
J Neurochem; 2005 Aug; 94(4):1040-53. PubMed ID: 16092945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
